TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients.

Joshua T Kantrowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.